CompletedInterventionalPhase 1Last updated Aug 24, 2015

A Study to Evaluate the Effects of Tedizolid Phosphate on the Pharmacokinetics and Safety of Midazolam and Rosuvastatin (MK-1986-004)

A Multiple-Dose Study to Evaluate the Effects of Steady-State Tedizolid Phosphate Administration on the Pharmacokinetics and Safety of a Single Dose of Midazolam and Rosuvastatin

Overview

ClinicalTrials.gov ID: NCT02477514
Lead Sponsor: Merck Sharp & Dohme LLCINDUSTRY
Brief Summary: The purpose of this study is to assess the effect of steady-state tedizolid phosphate on the single-dose pharmacokinetics of midazolam and rosuvastatin in healthy, adult participants.
Study Type: Interventional

Status

Overall Status: Completed
Start Date: Jun 2015
Primary Completion Date: Aug 2015Actual
Completion Date: Aug 2015Actual

Study Record Dates

First Submitted: Jun 17, 2015
First Submitted that Met QC Criteria: Jun 17, 2015
First Posted: Jun 22, 2015Estimated
Last Update Submitted that Met QC Criteria: Aug 21, 2015
Last Update Posted: Aug 24, 2015Estimated
Last Verified: Aug 2015

NCT06111521Completed

A Drug-Drug Interaction Study of LY3537982 on Midazolam, Digoxin, and Rosuvastatin in Healthy Participants

NCT06979973Completed

A Drug-drug Interaction Study to Investigate the Pharmacokinetic Interactions Between CKD-508, Midazolam, and Rosuvastatin in Healthy Adult Male Participants

NCT06733688Completed

A Study to Evaluate Oral Formulations of Tedizolid Phosphate in Healthy Participants (MK-1986-043)

NCT03311841Completed

Pharmacokinetics of Midazolam, Dabigatran, Pitavastatin, Atorvastatin, and Rosuvastatin in Participants With Renal Insufficiency in the Presence and Absence of Rifampin (MK-0000-386)

NCT03174041Completed

A Drug-Drug Interaction Study Between GDC-0853 and Midazolam, Itraconazole, Rosuvastatin, and Simvastatin

NCT01402076Completed

A Study to Assess the Effect Tasimelteon on the Cytochrome P450 3A4 and 2C8 Enzymes in Healthy Subjects